Cargando…

TBOPP enhances the anticancer effect of cisplatin by inhibiting DOCK1 in renal cell carcinoma

The treatment of renal cell carcinoma (RCC) with chemotherapy remains a challenge; therefore, improving the knowledge of the molecular mechanisms underlying RCC chemoresistance and developing novel therapeutic strategies is important. Dedicator of cytokinesis 1 (DOCK1), the first member of the DOCK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Zheng, Xiaoxiao, Xie, Shangzhi, Zhang, Shufen, Mao, Jiayan, Cai, Ying, Lu, Xuemei, Chen, Wei, Ni, Haibin, Xie, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339706/ https://www.ncbi.nlm.nih.gov/pubmed/32626999 http://dx.doi.org/10.3892/mmr.2020.11243

Ejemplares similares

MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer
por: Wang, Hui, et al.
Publicado: (2020)

miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
por: Zhou, Yue, et al.
Publicado: (2019)

Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
por: Wu, Ying, et al.
Publicado: (2020)

Annexin A9 promotes cell proliferation by regulating the Wnt signaling pathway in colorectal cancer
por: Lu, Xuemei, et al.
Publicado: (2023)

LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway
por: Zhang, Jinyan, et al.
Publicado: (2021)

miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
por: Du, Feiya, et al.
Publicado: (2019)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway
por: Gao, Xianxian, et al.
Publicado: (2021)

Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract
por: Hu, Xiaomeng, et al.
Publicado: (2022)

EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
por: Samaržija, Ivana, et al.
Publicado: (2022)

Transportan 10 improves the anticancer activity of cisplatin
por: Izabela, Rusiecka, et al.
Publicado: (2016)

Antiviral and Anticancer Activity of Cisplatin Derivatives of Tilorone
por: Roner, Michael R., et al.
Publicado: (2008)

Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer
por: Zhang, Hui, et al.
Publicado: (2018)

Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents
por: Warsito, Warsito, et al.
Publicado: (2021)

Cellular accumulation of the anticancer agent cisplatin: a review.
por: Gately, D. P., et al.
Publicado: (1993)

Erratum to: Transportan 10 improves the anticancer activity of cisplatin
por: Rusiecka, Izabela, et al.
Publicado: (2016)

Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome
por: Melnikov, Sergey V., et al.
Publicado: (2016)

Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy
por: Tang, Yuexiao, et al.
Publicado: (2020)

Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70
por: Endo, H, et al.
Publicado: (2014)

Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance
por: Xu, Guodong, et al.
Publicado: (2022)

Anticancer, Anticoagulant, Antioxidant and Antimicrobial Activities of Thevetia peruviana Latex with Molecular Docking of Antimicrobial and Anticancer Activities
por: Al-Rajhi, Aisha M. H., et al.
Publicado: (2022)

Cisplatin-induced renal toxicity in elderly people
por: Duan, ZhiYu, et al.
Publicado: (2020)

On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy
por: Gómez-Ruiz, Santiago, et al.
Publicado: (2012)

Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2019)

Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
por: Qi, Xiaofeng, et al.
Publicado: (2016)

Based on network pharmacology and molecular docking to explore the protective effect of Epimedii Folium extract on cisplatin-induced intestinal injury in mice
por: Xia, Juan, et al.
Publicado: (2022)

Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition
por: Chen, Da-jin, et al.
Publicado: (2016)

Hepatic Ischemic Preconditioning Alleviates Ischemia-Reperfusion Injury by Decreasing TIM4 Expression
por: Zhang, Yu, et al.
Publicado: (2018)

Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA
por: Sandhiutami, Ni Made Dwi, et al.
Publicado: (2021)

Erratum: Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
por: Qi, Xiaofeng, et al.
Publicado: (2017)

Antioxidant, anticancer activity and molecular docking study of lycopene with different ratios of Z-isomers
por: Wang, Haiyan, et al.
Publicado: (2023)

Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs as Anticancer Agents Targeting EGFR
por: Yang, Yong-An, et al.
Publicado: (2014)

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
por: Xu, Yunjie, et al.
Publicado: (2018)

Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway
por: Zhang, Jian, et al.
Publicado: (2020)

3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition
por: Alam, Sarfaraz, et al.
Publicado: (2019)

Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin
por: Wenande, Emily, et al.
Publicado: (2018)

Exo-Functionalized Metallacages as Host-Guest Systems for the Anticancer Drug Cisplatin
por: Woods, Ben, et al.
Publicado: (2019)

Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
por: Calcabrini, Cinzia, et al.
Publicado: (2020)

Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity
por: El-Sheikh, Azza, et al.
Publicado: (2021)

Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
por: Zhong, Yanan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ficnmcm8nbtgriib5l73qca6v